A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies

NCT01054352 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: JNJ38224342
DRUG: JNJ38224342/placebo
DRUG: JNJ38224342/placebo
DRUG: JNJ38224342/placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.